Corrigendum to: Combined Therapy with Probiotic VSL#3 and Omega-3 Fatty Acids Attenuates Colonic Injury and Inflammation in Chronic DNBS-induced Colitis in Mice

Abstract

We published the abovementioned article about probiotic mixture VSL#3 on October 6, 2021. Since the product was named VSL#3 in our purchasing process in early 2016, it is referred to as VSL#3 in our article. In addition, the product currently known as VSL#3 is not the same as De Simone Formulation. De Simone Formulation is now available as Visbiome® in the United States and Vivomixx® in Europe. The authors would like to apologise for any inconvenience caused

Chemoprevention effect of the Mediterranean diet on colorectal cancer: Current studies and future prospects

“…Administration of combination reduced the concentrations of inflammatory mediators such as IFN-γ, TNF-α, and IL-17A. The findings showed that the combined effect of probiotics and n-3 PUFA might have a protective effect against colon injury and inflammation by creating synergistic effects ( 306 ). Moreover, the anti-inflammatory effect of n-3 PUFA was investigated in a rat model of acetic acid-induced UC.…”